top of page

Feature Article | Leen Kawas on Redefining Capital Efficiency in Biotechnology Development

  • chance51029
  • Jan 2
  • 1 min read
Illustrated portrait of Leen Kawas, a woman with straight dark hair and glasses, wearing a navy blazer and holding a molecular model in a science lab setting. She is assembling connected spheres representing biotech innovation, with a beaker subtly visible in the background.

Biotech doesn’t have to cost hundreds of millions to get off the ground. This article follows Leen Kawas’s argument that the industry’s biggest problem isn’t science, it’s redundancy: expensive habits that stuck around because “that’s how it’s always done.” It breaks down where those inefficiencies hide, how founders can use technology (including AI) to streamline workflows without cutting corners, and what “capital-efficient” drug development actually looks like in practice when quality still has to be non-negotiable.



 
 
 

Comments

bottom of page